BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37088815)

  • 1. Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age.
    Guo Z; Jin F; Chen S; Hu P; Hao Y; Yu Q
    BMC Endocr Disord; 2023 Apr; 23(1):89. PubMed ID: 37088815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome.
    Leerasiri P; Wongwananuruk T; Indhavivadhana S; Techatraisak K; Rattanachaiyanont M; Angsuwathana S
    J Obstet Gynaecol Res; 2016 Jun; 42(6):678-83. PubMed ID: 26890011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
    Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
    J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome.
    Yang Y; Ouyang N; Ye Y; Hu Q; Du T; Di N; Xu W; Azziz R; Yang D; Zhao X
    Reprod Biomed Online; 2020 Oct; 41(4):734-742. PubMed ID: 32912651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal and metabolic aspects of acne vulgaris in women with polycystic ovary syndrome.
    Franik G; Bizoń A; Włoch S; Kowalczyk K; Biernacka-Bartnik A; Madej P
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4411-4418. PubMed ID: 30058676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
    Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
    J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: A systematic review and meta-regression analysis.
    Amiri M; Ramezani Tehrani F; Nahidi F; Bidhendi Yarandi R; Behboudi-Gandevani S; Azizi F
    Clin Endocrinol (Oxf); 2017 Sep; 87(3):217-230. PubMed ID: 28575537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
    Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acne severity and the Global Acne Grading System in polycystic ovary syndrome.
    Hacivelioglu S; Gungor AN; Gencer M; Uysal A; Hizli D; Koc E; Cosar E
    Int J Gynaecol Obstet; 2013 Oct; 123(1):33-6. PubMed ID: 23948280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.
    Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J
    Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
    Hahn S; Kuehnel W; Tan S; Kramer K; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
    Clin Chem Lab Med; 2007; 45(2):202-7. PubMed ID: 17311509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
    Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of biochemical markers and clinical signs of hyperandrogenism in women with polycystic ovary syndrome (PCOS) and women with non-classic congenital adrenal hyperplasia (NCAH).
    Chanukvadze D; Kristesashvili J; Kvashilava N
    Iran J Reprod Med; 2012 Jul; 10(4):307-14. PubMed ID: 25246891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40.
    Liang SJ; Hsu CS; Tzeng CR; Chen CH; Hsu MI
    Hum Reprod; 2011 Dec; 26(12):3443-9. PubMed ID: 21926412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
    Zhang HY; Guo CX; Zhu FF; Qu PP; Lin WJ; Xiong J
    Arch Gynecol Obstet; 2013 Mar; 287(3):525-31. PubMed ID: 23108387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
    Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
    Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.